Associated Papers
The IKZF1 N159S mutation is associated with poor outcome and a distinct molecular profile in adult patients with AML.
Stasik S et al.
British Journal of Haematology, 2025
40041934 (PubMed )
Supplement: BJH-206-1373-s001.zip › BJH20027-sup-0001-Supplementary-Material.docx
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia.
Eckardt JN et al.
Leukemia, 2023
37833543 (PubMed )
Supplement: 41375_2023_2061_MOESM1_ESM.docx
Reprogramming of Acute Myeloid Leukemia Patients Cells: Harboring Cancer Mutations Requires Targeting of AML Hierarchy.
Golubeva D et al.
Stem Cells Translational Medicine, 2023
Platelet transcriptome analysis in patients with germline RUNX1 mutations.
Palma-Barqueros V et al.
Journal of Thrombosis and Haemostasis : Jth, 2023
Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders.
Bastida JM et al.
Haematologica, 2018
Select a paper to view details